Bioactivity of natural biflavonoids in metabolism-related disease and cancer therapies.
Pharmacol Res
; 167: 105525, 2021 05.
Article
in En
| MEDLINE
| ID: mdl-33667686
Key words
2,3-Dihydroamentoflavone (Pubchem CID-44420106); 2',8â³-Biapigenin (Pubchem CID-11958336); 3,8â³-Biapigenin (Pubchem CID-10414856); 6,6â³-Biapigenin (Pubchem CID-23757236); 7,7â³-Dimethoxyagastisflavone (Pubchem CID-9985405); Agathisflavone (Pubchem CID-5281599); Alzheimer's; Amentoflavone (Pubchem CID-5281600); Angiogenesis; Anticancer; Apoptosis induction; Biacacetin (Pubchem CID-122179776); Biflavonoids; Bilobetin (Pubchem CID-5315459); Bioavailability; Chamaejasmenin B (Pubchem CID-21676273); Diabetic agent; Dihydromorelloflavone (Pubchem CID-11467081); Fatty acid synthase; Fukugeside (Pubchem CID-101560895); Ginkgetin (Pubchem CID-5271805); Glucosidase inhibition; Hinokiflavone (Pubchem CID-5281627); Isochamaejasmenin B (Pubchem CID-11753405); Isoginkgetin (Pubchem CID-5318569); Metastasis; Morelloflavone (Pubchem CID-5464454); Obesity therapy; Ochnaflavone (Pubchem CID-5492110); PPAR-γ expression; PTP1B inhibitors; Pancreatic lipase; Sciadopitysin (Pubchem CID-5281696); Taiwaniaflavone (Pubchem CID-44456685); Volkensiflavone (Pubchem CID-5480834)
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Plantas_medicinales
Main subject:
Biflavonoids
/
Metabolic Diseases
/
Neoplasms
/
Antineoplastic Agents, Phytogenic
Language:
En
Journal:
Pharmacol Res
Year:
2021
Type:
Article
Affiliation country:
Japan